Skip to main content
Broncus Holding Corporation logo

Broncus Holding Corporation — Investor Relations & Filings

Ticker · 2216 HKEX Manufacturing
Filings indexed 194 across all filing types
Latest filing 2026-04-20 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2216

About Broncus Holding Corporation

http://www.broncus.com

Broncus Holding Corporation is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company is recognized as a pioneer in the field of interventional pulmonology. Broncus provides comprehensive solutions across the spectrum of lung care, including advanced diagnostic solutions, lung cancer treatment solutions, and specialized solutions for chronic obstructive pulmonary disease (COPD). Its product portfolio consists of medical devices and consumables designed to improve patient outcomes in global markets, including Mainland China and the European Union.

Recent filings

Filing Released Lang Actions
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
Regulatory Filings
2026-04-20 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2026-04-20 English
(1) PROPOSALS FOR THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY AND ITS SUBSIDIARIES AND THE REPORTS OF THE DIRECTORS AND AUDITOR FOR THE YEAR ENDED DECEMBER 31, 2025; (2) RE-ELECTION O
Regulatory Filings
2026-04-20 English
Annual Report 2025
Regulatory Filings
2026-04-20 English
DELAY IN DESPATCH OF CIRCULAR MAJOR TRANSACTION FURTHER ACQUISITION OF TARGET SHARES IN THE TARGET COMPANY
Report Publication Announcement Classification · 1% confidence The document is an announcement by Broncus Holding Corporation regarding the delay in despatch of its Circular for a major transaction. It does not contain the actual circular or detailed transaction documents, but only notifies shareholders of a change in the timing of its publication. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports or circulars.
2026-04-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Share Issue/Capital Change Classification · 1% confidence The document is a mandatory monthly return (Form FF301) filed with the Hong Kong Stock Exchange under Listing Chapter 19B, detailing movements in authorised share capital, issued shares, treasury shares, share options, RSU scheme, and confirmations regarding public float. It is not announcing earnings, dividends, board changes, or legal matters. It primarily relates to share capital and security movements, fitting the “Share Issue/Capital Change” category. Thus, the appropriate classification is SHA.
2026-04-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.